Monitoring donor-derived cell-free DNA is a noninvasive means of detecting antibody-mediated rejection of a transplanted ...

A groundbreaking study has identified circulating cell-free DNA as a potential biomarker for predicting early relapse in ...

Traditional biomarkers used in kidney transplant care lack sensitivity and specificity for early detection Donor-derived cell-free DNA is used as a biomarker for detecting early graft rejection or ...

Liquid biopsy techniques using cell-free DNA (cfDNA) play an increasingly important role in the characterization and surveillance of solid tumors. For blood cancers, molecular response assessment ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, ...

Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood. This approach focuses on shuffled ...